MK-3475 in Melanoma and NSCLC Patients With Brain Metastases

Clinical trial NCT02085070 · COMPLETED

Trial details

NCT number: NCT02085070
Sponsor: Yale University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Melanoma Non-Small Cell Lung Cancer Brain Metastases

Start date: 2014-03-01
Primary completion: 2020-02-27
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.